270 related articles for article (PubMed ID: 14758001)
1. Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Thangavel S
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):178-85. PubMed ID: 14758001
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological activities of some mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Sivakumar T
Bioorg Med Chem; 2005 Oct; 13(20):5766-73. PubMed ID: 15982893
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
[TBL] [Abstract][Full Text] [Related]
7. Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity.
Mandal AA; Upadhyay A; Mandal A; Nayak M; K MS; Mukherjee S; Banerjee S
ACS Appl Mater Interfaces; 2024 Jun; 16(22):28118-28133. PubMed ID: 38783713
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic and antibacterial activity of some mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Bhattacharya S; Karki SS; Rathinasamy S; Thangavel S
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):185-92. PubMed ID: 15449735
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of certain mononuclear Ru (II) complexes.
Rathinasamy S; Karki SS; Bhattacharya S; Manikandan L; Prabakaran SG; Gupta M; Mazumder UK
J Enzyme Inhib Med Chem; 2006 Oct; 21(5):501-7. PubMed ID: 17194018
[TBL] [Abstract][Full Text] [Related]
10. Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.
Huang H; Zhang P; Chen Y; Ji L; Chao H
Dalton Trans; 2015 Sep; 44(35):15602-10. PubMed ID: 26245234
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF
Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660
[TBL] [Abstract][Full Text] [Related]
12. Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes.
Malik MA; Raza MK; Dar OA; Amadudin ; Abid M; Wani MY; Al-Bogami AS; Hashmi AA
Bioorg Chem; 2019 Jun; 87():773-782. PubMed ID: 30974300
[TBL] [Abstract][Full Text] [Related]
13. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA
Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes.
Thota S; Karki SS; Jayaveera KN; Balzarini J; De Clercq E
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):513-9. PubMed ID: 20128638
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, DNA-binding, cytotoxicity, photo cleavage, antimicrobial and docking studies of Ru(II) polypyridyl complexes.
Srishailam A; Kumar YP; Gabra NM; Reddy PV; Deepika N; Veerababu N; Satyanarayana S
J Fluoresc; 2013 Sep; 23(5):897-908. PubMed ID: 23553642
[TBL] [Abstract][Full Text] [Related]
16. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of novel half-sandwich Ru(II) complexes bearing pyrazalone moiety: Apoptosis inducers based on mitochondrial dysfunction and G0/G1 arrest.
Huang Y; Huang S; Wei W; Wu Y; Jia L; Du Y; Luo P; Pan W
J Inorg Biochem; 2024 Jan; 250():112421. PubMed ID: 37922609
[TBL] [Abstract][Full Text] [Related]
19. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, DNA binding studies, photocleavage, cytotoxicity and docking studies of ruthenium(II) light switch complexes.
Gabra NM; Mustafa B; Kumar YP; Devi CS; Srishailam A; Reddy PV; Reddy KL; Satyanarayana S
J Fluoresc; 2014 Jan; 24(1):169-81. PubMed ID: 23982735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
